What OOS Investigation Audits Cover
An out of specification result is any test result that falls outside the specifications established for the product, material, or method. OOS results can indicate a laboratory error, a manufacturing problem, or a product that does not meet its specifications. The investigation determines which.
A GMP audit for OOS investigations assesses whether investigations are thorough, whether they follow a defined process, whether they reach a defensible conclusion, and whether corrective actions prevent recurrence. The scope includes the laboratory investigation phase, the full scale investigation phase, the conclusion, and the CAPA that follows.
The Regulatory Context
FDA 21 CFR 211.192 and 211.160
The FDA requires that discrepancies be investigated under 21 CFR 211.192, and that laboratory controls be established under 211.160. The agency has published guidance on investigating OOS test results that describes a two phase approach.
EU GMP Chapter 6
Chapter 6 of EudraLex Volume 4 covers quality control, including investigation of results that do not meet specifications.
MHRA Data Integrity Guidance
The MHRA guidance applies to OOS investigations because the integrity of the data and the investigation record determines whether the conclusion can be trusted.
PIC/S and WHO
PIC/S Guide PE 009 and WHO GMP guidelines cover laboratory investigations as part of the broader GMP framework.
What Audits Focus On
Phase I Laboratory Investigation
The laboratory investigation should determine whether the OOS result is due to a laboratory error. The audit should check that the investigation is thorough, that it is documented, and that the conclusion is supported by evidence.
Phase II Full Investigation
If the laboratory investigation does not identify a laboratory error, a full investigation should be conducted. The audit should check that the investigation covers manufacturing, materials, methods, and equipment, and that it reaches a root cause.
Hypothesis Testing
Investigations should test hypotheses rather than assume a conclusion. The audit should check that hypotheses are documented and that testing is performed.
Conclusion and Batch Decision
The conclusion should determine whether the batch is rejected or released, and whether retesting is appropriate. The audit should check that the conclusion is supported and that the batch decision is documented.
CAPA
The investigation should lead to corrective and preventive actions. The audit should check that CAPAs address root cause and that effectiveness is verified.
Documentation
Investigations should be documented contemporaneously. The audit should check that the record is complete and traceable.
Common Findings in OOS Investigation Audits
Phase I Investigations That Are Incomplete
Conclusions That Are Not Supported by Evidence
Retesting Without Justification
Investigations That Do Not Reach Root Cause
CAPAs That Do Not Prevent Recurrence
Documentation Gaps
Introducing GxP Cellators for OOS Investigation Audits
GxP Cellators provides GMP audits for OOS investigations covering Phase I laboratory investigations, Phase II full investigations, hypothesis testing, conclusions, batch decisions, CAPA, and documentation.
We work across FDA, EMA, Health Canada, MHRA, WHO, and PIC/S frameworks, and we adapt the audit scope to the laboratory and manufacturing systems in use. Our auditors bring regulatory inspection and industry quality experience, and we deliver clear, prioritized reports with practical remediation guidance.
Get to the Root Cause
Visit https://www.gxpcellators.com/gmp-auditing/ for service details. Email or use https://www.gxpcellators.com/contact/ to discuss your OOS investigation audit.
Frequently Asked Questions About OOS Investigation Audits
What is an OOS result?
An OOS result is any test result that falls outside the specifications established for the product, material, or method.
What is Phase I of an OOS investigation?
Phase I is the laboratory investigation to determine whether the OOS result is due to a laboratory error.
What is Phase II of an OOS investigation?
Phase II is the full investigation conducted if Phase I does not identify a laboratory error.
When is retesting appropriate?
Retesting is appropriate when the investigation supports it and when the retesting plan is defined in advance. Retesting without justification is a finding.
How do you assess the conclusion?
We review the evidence to confirm that the conclusion is supported and that the batch decision is documented.
Can you help us prepare for an inspection of OOS investigations?
Yes. We conduct readiness reviews and mock inspections.
How do I request an OOS investigation audit?
Email or use https://www.gxpcellators.com/contact/. Service details are at https://www.gxpcellators.com/gmp-auditing/.
